popular stocks Archives

Cabot Undervalued Stocks Advisor Special Bulletin

August 23, 2019|From Cabot Undervalued Stocks Advisor|by Crista Huff|Value Investing

A Spanish news outlet, Intereconomia.com, is reporting that biotech company Amgen (AMGN) is in talks to buy Alexion Pharmaceuticals (ALXN) for close to $200 per share.
Read More

Cabot Global Stocks Explorer 692

From the Cabot Global Stocks Explorer 692 issue of Cabot Global Stocks Explorer|by sarahd|Emerging Markets

Our Emerging Markets Timer as found support in recent weeks, but that hasn’t been enough to produce a new buy signal.
Read More

Cabot Stock of the Week 261

From the Cabot Stock of the Week 261 issue of Cabot Stock of the Week|by sarahd|Stock Market

The market remains strong and I continue to recommend that you be heavily invested in a well-diversified portfolio that meets your investment needs.
Read More

Cabot Marijuana Investor Update

August 14, 2019|From Cabot Marijuana Investor|by Timothy Lutts|Growth Stocks

Yesterday’s strong market triggered a technical indicator, a follow-through signal that tells us buyers are lurking. Of course, today’s big decline so far isn’t good to see, but nevertheless, this and other measures (awful sentiment, etc.) tell us there should be support on weakness.
Read More

Cabot Growth Investor 1426

From the Cabot Growth Investor 1426 issue of Cabot Growth Investor|by sueh|Growth Stocks

Play Some Defense Usually, when the market is doing well, stocks aren’t affected much by the news of the day. That’s not to say individual stocks don’t get pushed around, but for the market as a whole, worrisome headline news usually goes the way water...
Read More

Cabot Stock of the Week 260

From the Cabot Stock of the Week 260 issue of Cabot Stock of the Week|by sueh|Stock Market

The market remains strong and I continue to recommend that you be heavily invested in a well-diversified portfolio that meets your investment needs.
Read More

Cabot Marijuana Investor Update

August 12, 2019|From Cabot Marijuana Investor|by Timothy Lutts|Growth Stocks

The good news is that many cannabis companies have been releasing their second quarter reports and the results have been excellent.
Read More

Cabot Undervalued Stocks Advisor Special Bulletin

August 9, 2019|From Cabot Undervalued Stocks Advisor|by Crista Huff|Value Investing

Four stocks in our portfolios reported earnings this week.
Read More

Cabot Global Stocks Explorer 691

From the Cabot Global Stocks Explorer 691 issue of Cabot Global Stocks Explorer|by sarahd|Emerging Markets

Emerging markets (EEM) moved more solidly into bullish territory this week moving ahead of both its 20-day and 50-day moving averages.
Read More

Cabot Stock of the Week 259

From the Cabot Stock of the Week 259 issue of Cabot Stock of the Week|by sueh|Stock Market

The market remains strong and I continue to recommend that you be heavily invested in a well-diversified portfolio that meets your investment needs.
Read More

Cabot Undervalued Stocks Advisor 819

From the Cabot Undervalued Stocks Advisor 819 issue of Cabot Undervalued Stocks Advisor|by sueh|Value Investing

Trade War Turmoil Trumps a Good Earnings Season U.S. stock markets took quite a tumble in the last few business days. For those of you wondering, “Should I buy low?”, the answer to that question is usually “yes, but let’s first wait for the to...
Read More

Cabot Marijuana Investor Update

August 5, 2019|From Cabot Marijuana Investor|by Timothy Lutts|Growth Stocks

The cannabis sector is still in correction mode ... looking for a bottom somewhere.
Read More

Cabot Growth Investor 1425

From the Cabot Growth Investor 1425 issue of Cabot Growth Investor|by sueh|Growth Stocks

Passing T-Storms­—or Something More? On this page of the last issue, we wrote “we think the near-term is a toss-up, at least when it comes to individual growth stocks— earnings season is always tricky, and let’s face it, many leaders have had great runs the...
Read More

Cabot Marijuana Investor Update

August 1, 2019|From Cabot Marijuana Investor|by Timothy Lutts|Growth Stocks

While long-term prospects for the cannabis industry remain excellent, the sector as a whole remains in correction mode today, with the big Canadian stocks under the greatest pressure—and no one knows where the bottom is, though history tells us it will come when last...
Read More

Cabot Undervalued Stocks Advisor Special Bulletin

August 1, 2019|From Cabot Undervalued Stocks Advisor|by Crista Huff|Value Investing

Crista is changing the rating on two stocks and retiring another.
Read More

Cabot Undervalued Stocks Advisor Special Bulletin

July 31, 2019|From Cabot Undervalued Stocks Advisor|by Crista Huff|Value Investing

Crista reports good earnings announcements in five portfolio stocks.
Read More

Cabot Stock of the Week 258

From the Cabot Stock of the Week 258 issue of Cabot Stock of the Week|by sueh|Stock Market

The market remains strong and I continue to recommend that you be heavily invested in a well-diversified portfolio that meets your investment needs.
Read More

Cabot Global Stocks Explorer 690

From the Cabot Global Stocks Explorer 690 issue of Cabot Global Stocks Explorer|by sueh|Emerging Markets

Emerging markets (EEM) moved more solidly into bullish territory this week moving ahead of both its 20-day and 50-day moving averages.
Read More

Cabot Marijuana Investor 719

From the Cabot Marijuana Investor 719 issue of Cabot Marijuana Investor|by sueh|Stock Market

Bad News Bears The stock market in general is quite healthy, with the major indexes at or near their highs, and all Cabot’s market timing indicators positive. But the cannabis sector is still weak. Part of this weakness stems from the fact that cannabis was the sector...
Read More

Cabot Undervalued Stocks Advisor Special Bulletin

July 25, 2019|From Cabot Undervalued Stocks Advisor|by Crista Huff|Value Investing

Thus far, the 11 portfolio companies that delivered second-quarter results have all met or exceeded Wall Street’s consensus earnings estimates.
Read More